What is the enterprise value (EV) for Bio-Rad Laboratories, Inc. (BIO)?

The enterprise value (EV) for BIO stock is $11.08B.

Bio-Rad Laboratories (BIO) Enterprise Value: History & Chart

Compare

Bio-Rad Laboratories, Inc.(BIO)

Medical - Devices · Hercules, CA

$380.12-5.99 (-1.55%)

Delayed quote: Sep 8, 2026, 4:00 PM EDT

Compare

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA

7,450 employees

www.bio-rad.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Norman D. Schwartz

View full financials

NAME	MARKET CAP	ENTERPRISE VALUE (EV)
Bio-Rad Laboratories, Inc. (BIO)	$10.23B	$11.08B
Molina Healthcare, Inc. (MOH)vs ›	$10.25B	$9.21B
Henry Schein, Inc. (HSIC)vs ›	$10.12B	$13.78B
Globus Medical, Inc. (GMED)vs ›	$10.12B	$9.82B
Universal Health Services, Inc. (UHS)vs ›	$10.41B	$15.37B
The Ensign Group, Inc. (ENSG)vs ›	$9.94B	$12.00B
Insulet Corp. (PODD)vs ›	$9.85B	$10.27B
Align Technology, Inc. (ALGN)vs ›	$10.99B	$10.01B
Tempus AI, Inc. (TEM)vs ›	$11.26B	$12.22B
Bio-Techne Corporation (TECH)vs ›	$11.32B	$11.35B

NAME

MARKET CAP

ENTERPRISE VALUE (EV)

Bio-Rad Laboratories, Inc. (BIO)

$10.23B

$11.08B

Molina Healthcare, Inc. (MOH)vs ›

$10.25B

$9.21B

Henry Schein, Inc. (HSIC)vs ›

$10.12B

$13.78B